2. Its a continuum, with incremental degrees of
physiologic derangements in individual organs.
It is a process rather than a single event.
Alteration in organ function can vary widely from a
mild degree to completely irreversible organ failure.
MODS is defined as a clinical syndrome characterized
by the development of progressive and potentially
reversible physiologic dysfunction in 2 or more
organs or organ systems that is induced by a variety of
acute insults, including sepsis.
7. SIRS may follow a variety of clinical insults, including
infection, pancreatitis, ischemia, polytrauma, tissue
injury, hemorrhagic shock, or immune-mediated
organ injury.
Sepsis is a systemic response to infection.
It is identical to SIRS, except that it must result
specifically from infection rather than from any
noninfectious insults.
Sepsis and SIRS are phenotypically similar, having a
common inflammatory pathway causing both.
8. Septic shock is defined as a subset of sepsis in which
profound circulatory, cellular, and metabolic
abnormalities are associated with a greater risk of
mortality than with sepsis alone.
Clinically identified by a vasopressor requirement to
maintain a mean arterial pressure of 65 mm Hg or
greater and serum lactate level greater than 2 mmol/L
in the absence of hypovolemia.
associated with hospital mortality rates greater than
40%.
9. Organ dysfunction is represented by an increase in the
Sequential [sepsis-related] SOFA scoreof 2 points or
more, which is associated with an in-hospital
mortality greater than 10%.
Primary MODS is the direct result of a well-defined
insult in which organ dysfunction occurs early and can
be directly attributable to the insult itself.
Secondary MODS develops as a consequence of a
host response and is identified within the context of
SIRS.
10.
11. In out-of-hospital, emergency department or general
hospital ward settings, adult patients with suspected
infection can be rapidly identified as being more likely
to have poor outcomes if they have at least two of the
following clinical criteria that together constitute a
new bedside clinical score termed quick SOFA
(qSOFA)
respiratory rate of 22/min or greater.
altered mental status
systolic blood pressure of 100 mm Hg or less.
12.
13. Pathogenesis..
Can be defined in 2 ways:
Intervention employed to support the failing organ
system( mehanical ventilation, vasopressor, HD,TPN)
Acute physiologic derangements that made such
intervention necessary.
14.
15.
16. Upragulation of both proinflammatory and anti-
inflammatory mediators suggesting that failure of host
defence homeostasis is the final pathway from sepsis to
MODS, rather than simple hypotension-induced end-
organ injury, as may occur with hemorrhagic shock.
Survival from severe sepsis with MODS is usually
associated with a generalized reduction in both the
proinflammatory and anti-inflammatory response.
MODS may by the host’s adaptive response to
overwhelming inflammation, allowing inflammation to
clear without causing permanent end-organ harm.
18. Cardiovascular...
Circulating myocardial depressant factor: the synergistic
effects of TNF-α, IL-1β, other cytokines, and NO.
Reversible myocardial depression resistant to
catecholamines and fluid.
5 components: reduction in net oxygen delivery
Reduction in PVR
Diffuse capillary leak
Alteration of organ specific blood flow
Microvascular plugging
Myocardial depression
19. Early response Late response
Myocardial depression
Fall in SVR
Fall in RAP
Rise in venous capicitance
Rise in HR, CO, DO2
Ventricles dilate
Decreased contractility
Decrease in CO
Requirement of vasopressures
22. Other factors:
Stress ulcer
Septic shock can cause paralytic ileus: delay in the
institution of enteral feeding.
Excess NO production: agent of sepsis-induced ileus.
High protein and calorie requirements.
Narcotics and muscle relaxants: worsen GI tract motility.
23. Hepatobiliary...
The hepatic reticuloendothelial system dysfunction
leads to a spillover of toxins into systemic circulation.
Inchemic hepatitis, acalculus cholelithiasis
Menifestations:
elevations in liver enzymes and bilirubin
coagulation defects
failure to excrete toxins such as ammonia:
encephalopathy
Acute phase response
24. Renal...
Mechanism of AKI is complex: decrease in effective
intravascular volume, direct renal vasoconstriction, release
of cytokines, and activation of neutrophils by endotoxins
and other peptides.
Mostly renal and prerenal causes:
Hypovolemia
Nephrotoxic drugs
Vasopressors
Abdominal compartment syndrome
Infectious
25. Challenges:
To rule out obstructive causes.
To differentiate prerenal causes from ATN.
To estimate intravascular volume status.
Adequacy of fluid therapy.
27. Coagulopathy...
Subclinical coagulopathy:
mild elevation of the thrombin time (TT)
activated partial thromboplastin time (aPTT)
moderate reduction in the platelet count.
Overt disseminated intravascular coagulation (DIC)
may also develop.
30. Workup...
CBC with DC:
adequate Hb concentration is necessary to ensure oxygen
delivery.
Neutrophil band count higher than 1500/µL is associated with
a high likelihood of bacterial infection.
Acute-phase reactants.
ABG
Coagulation studies.
A metabolic assessment:
serum electrolytes, including magnesium, calcium,
phosphate, and glucose, at regular intervals.
Renal and hepatic function.
31. Blood CS
Urine analysis and CS: 15% incidence of occult UTI
Secretion or tissue gram stain and CS
CSF studies
Imaging
Others:
serum ammonia
Procalcitonin
kidney injury molecules.
33. Approach...
Principles:
Decrease severity of risk factors
Prevent inflammation: drainage, antibiotics
Resuscitation and infection control
Treat malnutrition
Treat and support the organ systems.
Correction of ischemia
Stabilization of internal environment: acis-base, electrolytes
Glycemic control
34.
35.
36. Antimicrobial therapy...
Goal : effective IV antimicrobials within the first hour of
recognition of septic shock and severe sepsis.
Initial empiric anti-infective therapy: one or more drugs that
have activity against all likely pathogens (bacterial and/or fungal
or viral) and that penetrate in adequate concentrations into
tissues presumed to be the source of sepsis
Reassess daily for potential deescalation
Use of low procalcitonin levels to assist the clinician in the
discontinuation of empiric antibiotics .
Combination empirical therapy for neutropenic patients with
severe sepsis and for patients with difficult-to-treat, multidrug-
resistant bacterial pathogens.
37. Duration of therapy typically 7-10 days; longer courses
may be appropriate in patients who have a slow clinical
response, undrainable foci of infection, bacteremia with
Staphylococcus aureus, some fungal and viral infections, or
immunologic deficiencies (including neutropenia)
Antiviral therapy initiated as early as possible in patients
with severe sepsis or septic shock of viral origin
Antimicrobial agents should not be used in patients with
severe inflammatory states determined to be of
noninfectious cause.
38. Vasopressors and inotropes...
Noradrenalin: no effects on splanchnic oxygen
consumption and hepatic glucose production, provided
adequate cardiac output is maintained.
Adrenalin: increased lactate concentration, potential
production of myocardial ischemia and arrhythmias, and
reduced splanchnic flow.
Dopamine: inotropic effect, which is useful in patients
who have concomitant reduced cardiac function
Phenylephrine: good choice when tachyarrhythmias limit
therapy with other vasopressors.
Vasopressin
Levosimendan
dobutamine
39. Challenges in our ICU...
Vigilant monitoring:
During routine care?
During transport?
Dyselectrolytemia and acid base abnormalities:
Approach for metabolic acidosis?
Glycaemic control:
target?
insulin regimen?
Nutrition:
Initiating feed..
Role of dietician?
DVT prophylaxis:
Timing
agents
Infection control team, own ICU protocol and training
40. Conclusion...
No definitive treatment
Management revolves around organ support
Emphasis on early recognition and prevention
Anti infective measures
Maintenance of tissue oxygenation, nutrition and
glycaemic control
Vigilant monitoring, scoring systems
41. Ongoing research...
administration of recombinant human activated
protein C (drotrecogin alfa) resulted in lower mortality
(24.7%) in the treatment group than in the placebo
group (30.8%)
Antibodies against gram-negative endotoxin
Gamma globulins
Monoclonal antibodies against tumor necrosis factor
Blockade of eicosanoid production
Blockade of interleukin (IL)–1 activity
Inhibition of nitric oxide (NO) synthase